Subretinal Triamcinolone Acetonide and Transpupillary Thermotherapy in Circumscribed Choroidal Hemangioma. A Case Report
Subretinal Triamcinolone Acetonide and Transpupillary Thermotherapy in Circumscribed Choroidal Hemangioma. A Case Report
Purpose: To evaluate the potential use of a combination of subretinal triamcinolone acetonide (TA) injection with transpupillary thermotherapy (TTT) in the treatment of circumscribed choroidal hemangioma (CCH) with exudative retinal detachment.
Case report: The clinical case of a 27-year-old patient demonstrates the treatment of CCH with exudative retinal detachment. We used a combination of subretinal injection of 4 mg preservative-free TA with the simultaneous partial aspiration of subretinal fluid in the first stage. After one week, when the retina was fully attached, TTT of CCH was used in the second stage. At Month 12, visual acuity in the left eye increased from light perception with projection to 20/400. Ultrasonography did not reveal any signs of choroidal masses or retinal detachment. During the follow-up period, 3 sessions of TTT were performed.
Conclusion: A combination of subretinal TA injection with TTT can be an alternative treatment for CCH with exudative retinal detachment.
Keywords:
Triamcinolone acetonide – exudative retinal detachment – circumscribed choroidal hemangioma – subretinal injection – transpupillary thermotherapy
Autoři:
Mykola Umanets; Taras Kustryn; Nataliya Pasyechnikova
Působiště autorů:
State Institution «The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine»
Vyšlo v časopise:
Čes. a slov. Oftal., 81, 2025, No. Ahead of Print, p. 1-5
Kategorie:
Kazuistika
doi:
https://doi.org/10.31348/2025/29
Souhrn
Purpose: To evaluate the potential use of a combination of subretinal triamcinolone acetonide (TA) injection with transpupillary thermotherapy (TTT) in the treatment of circumscribed choroidal hemangioma (CCH) with exudative retinal detachment.
Case report: The clinical case of a 27-year-old patient demonstrates the treatment of CCH with exudative retinal detachment. We used a combination of subretinal injection of 4 mg preservative-free TA with the simultaneous partial aspiration of subretinal fluid in the first stage. After one week, when the retina was fully attached, TTT of CCH was used in the second stage. At Month 12, visual acuity in the left eye increased from light perception with projection to 20/400. Ultrasonography did not reveal any signs of choroidal masses or retinal detachment. During the follow-up period, 3 sessions of TTT were performed.
Conclusion: A combination of subretinal TA injection with TTT can be an alternative treatment for CCH with exudative retinal detachment.
Štítky
OftalmologieČlánek vyšel v časopise
Česká a slovenská oftalmologie
2025 Číslo Ahead of Print
- Diagnostický algoritmus při podezření na syndrom periodické horečky
- Stillova choroba: vzácné a závažné systémové onemocnění
- Kontaktní dermatitida očních víček
- Pseudoxanthoma elasticum − vzácné onemocnění s dosud limitovanými možnostmi léčby
- Léčba chronické blefaritidy vyžaduje dlouhodobou péči
Nejčtenější v tomto čísle
- Clinical Outcomes of Preserflo MicroShunt versus Trabeculectomy: A Retrospective 6-Month Study
- Choroidal Neovascular Membrane in Pediatric Patients: Long-Term Outcomes of Anti-VEGF Therapy
- Idiopathic Corneal Thinning and Spontaneous Perforation at Early Adulthood. A Case Report
- Tear Film Dysfunction and its Association with Smartphone Usage in Adolescents